期刊文献+

脂代谢异常与多囊卵巢综合征 被引量:26

Dyslipidemia and polycystic ovary syndrome
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是一种异质性内分泌紊乱,与生殖异常(高雄激素血症、月经过少/闭经、不孕症、妊娠并发症增加)及代谢异常(脂代谢异常、代谢综合征和冠心病)有关。PCOS与代谢紊乱的关系已有大量研究,且大多研究表明PCOS妇女中的血脂异常较非PCOS的同龄妇女中更普遍,与肥胖及胰岛素抵抗密切相关。本文就肥胖相关的脂代谢异常与PCOS的关系做一综述,以便为PCOS的筛查、诊断、治疗及预防远期并发症提供临床指导。 Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder,which is associated with both reproductive abnormalities (hyperandrogenism,oligo/amenorrhea,infertility,increase of pregnancy complications) and metabolic abnormalities (dyslipidemia,metabolic syndrome) and coronary heart disease. There were many studies involving the relationship between PCOS and metabolic disturbances. The most studies reported that dyslipidemia was more prevalent in PCOS women than the women without PCOS at the same age,and it is closely related to obesity and insulin resistance (IR). This paper reviews the relationship between obesity-related dyslipidemia and PCOS in order to provide clinical guidance for screening,diagnosis,treatment and prevention of long-term complications of PCOS.
作者 陈丽 郝丽娟 CHEN Li;HAO Li-juan(Department of Reproductive Endocrinology,Chongqing Maternity & Childcare Hospital,Chongqing 401147)
出处 《生殖医学杂志》 CAS 2019年第7期836-839,共4页 Journal of Reproductive Medicine
基金 重庆市卫生局医学科研项目(2012-2-202)
关键词 多囊卵巢综合征 脂代谢异常 胰岛素抵抗 肥胖 代谢综合征 Polycystic ovary syndrome Dyslipidemia Insulin resistance Obesity Metabolic syndrome
  • 相关文献

参考文献3

二级参考文献28

  • 1邢小燕,杨文英,杨兆军.胰岛素抵抗指数在不同糖耐量人群中诊断代谢综合征的作用[J].中国糖尿病杂志,2004,12(3):182-186. 被引量:123
  • 2张丽娜,吕时铭.健康成年女性内生雌激素的变化与脂类代谢关系的探讨[J].放射免疫学杂志,2007,20(1):70-72. 被引量:5
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 4Banaszewska B, Pawelczyk L, Spaczynski RZ, et al. Effects of simvastatin and crossover trial [J]. J Clin Endocrinol Meta,2007, 92(2) :456-461.
  • 5Ozdemir S, Gorkemli H, Gezginc K, et al. Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome [J]. lnt J Gynaecol Obstet,2008,103( 1 ) :44-49.
  • 6Franks S. Polycystic ovary syndrome in adolescents [l]. Int J Obes (Lond) ,2008,32: 1035-1041.
  • 7Wild RA, Painter PC, Coulson PB, et al. Lipoprotein lipid concentrations and cardiovaseular risk in women with polycystic ovary syndrome [J]. J Clin Endocrinol Metab, 1985,61 (5) : 946- 951.
  • 8Berneis K, Rizzo M, Hersberger M, et al. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome [J]. Int J Clin Praet,2009,63( 1 ) :56-62.
  • 9Westerveld HE, Hoogendoorn M, de Jong AW, et al. Cardiometabolic abnormalities in the polycystic ovary, syndrome: Pharmacother- apeutic insights [J]. Pharmacol Ther,2008, 119( 3 ):223-241.
  • 10Lo JC, Feigenbaum SL, Yang J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome [J]. J Clin Endocrinol Metab,2006,91(4): 1357-1363.

共引文献91

同被引文献277

引证文献26

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部